Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lactoferrin binding by leukemia cell lines.

Y Yamada, T Amagasaki, D W Jacobsen

    Blood
    |July 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Homocysteine targeting of plasma proteins in hemodialysis patients.

    Kidney international·2006
    Same author

    Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel.

    Journal of the neurological sciences·2004
    Same author

    Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging.

    The journal of nutrition, health & aging·2003
    Same author

    Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects.

    Physiological research·2002
    Same author

    Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation.

    The Journal of biological chemistry·2001
    Same author

    A facile synthesis of homocysteine-cysteine mixed disulfide.

    Analytical biochemistry·2001

    Leukemia cells, including K562, possess lactoferrin binding sites distinct from other receptors. Lactoferrin binding to these cells may be linked to cell proliferation and electrostatic interactions.

    Area of Science:

    • Biochemistry
    • Cell Biology
    • Hematology

    Background:

    • Monocytes and macrophages express receptors for lactoferrin, an iron-binding protein.
    • Lactoferrin binding inhibits granulocyte-macrophage colony-stimulating factor production in these immune cells.

    Purpose of the Study:

    • To investigate the presence and characteristics of lactoferrin binding sites on human erythroid leukemia cells (K562).
    • To determine the relationship between lactoferrin binding and cellular factors like iron status and proliferation.

    Main Methods:

    • Rosette assay and immunofluorescence to detect lactoferrin binding sites.
    • Quantification of binding sites using 59Fe-lactoferrin.
    • Inhibition studies with transferrin, Fc portion of IgG, and protamine.

    Related Experiment Videos

  • Trypsin treatment and cytosine arabinoside exposure to assess binding characteristics.

    • Main Results:

    • K562 leukemia cells exhibit specific lactoferrin binding sites.
    • These sites are distinct from transferrin and Fc receptors and are sensitive to electrostatic forces and trypsin.
    • Lactoferrin binding is not regulated by iron status but decreases with inhibited cell proliferation.

    Conclusions:

    • Leukemia cells possess unique lactoferrin binding sites.
    • Lactoferrin binding may play a role in leukemia cell biology, potentially linked to proliferation.